| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:1274-1279.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation
A Prospective Cohort Study in Men in Eastern Finland
From the Research Institute of Public Health, University of Kuopio, Kuopio, Finland (T.-P.T., K.N., T.A.L., J.T.S.); the Department of Community Health and General Practice, University of Kuopio, Kuopio, Finland (T.-P.T., J.T.S.); and the Department of Medicine, University of Helsinki, Helsinki, Finland (K.K., T.H.).
Correspondence to Professor Jukka T. Salonen, Research Institute of Public Health, University of Kuopio, Harjulantie 1 B, 70210 Kuopio, Finland (or PO Box 1627, 70211 Kuopio, Finland). E-mail jukka.salonen{at}uku.fi
Background—Homozygosity for a relatively common Cys282Tyr mutation of the human hemochromatosis-associated (HFE) gene was recently found to account for most cases of hereditary hemochromatosis. Because excess iron has been postulated to enhance risk of vascular disease, we studied whether occurrence of this mutation was associated with increased risk of first acute myocardial infarction in healthy middle-aged men in a prospective cohort study.
Methods and Results—Study subjects were the 1150 participants in the population-based Kuopio Ischemic Heart Disease Risk Factor Study (KIHD), aged 42, 48, 54, or 60 years at baseline, who had no coronary heart disease at baseline and for whom a DNA sample was available. Information about myocardial infarctions was collected prospectively by use of FINMONICA (FINnish MONItoring of trends and determinants in CArdiovascular disease study) and hospital data. Events were classified by MONICA (MONItoring of trends and determinants in CArdiovascular disease study) diagnostic criteria. The HFE Cys282Tyr mutation was assayed by a solid-phase minisequencing technique. One subject was homozygous and 76 individuals were heterozygous for the HFE Cys282Tyr mutation (6.7%). During a mean follow-up of 9 years, 8 (10.4%) of 77 carriers and 60 (5.6%) of 1073 noncarriers experienced an acute myocardial infarction. In a Cox proportional hazards model allowing for the other strongest risk factors, the carriers had a 2.3-fold (95% CI 1.1 to 4.8; P=0.03) risk of acute myocardial infarction compared with noncarriers.
Conclusions—Male carriers of the common hemochromatosis gene mutation are at 2-fold risk for first acute myocardial infarction compared with noncarriers.
Key Words: epidemiology • hemochromatosis • iron • myocardial infarction
This article has been cited by other articles:
 |
|
 |
|
  P. C. Adams, J. S. Pankow, J. C. Barton, R. T. Acton, C. Leiendecker-Foster, G. D. McLaren, M. Speechley, and J. H. Eckfeldt HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol: The Hemochromatosis and Iron Overload Screening Study Circ Cardiovasc Genet, February 1, 2009; 2(1): 34 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Sun, J. Ma, N. Rifai, O. H. Franco, K. M. Rexrode, and F. B. Hu Excessive Body Iron Stores Are Not Associated with Risk of Coronary Heart Disease in Women J. Nutr., December 1, 2008; 138(12): 2436 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M Yunker, J. S Parboosingh, H. E Conradson, P. Faris, P. J Bridge, J. Buithieu, L. M Title, F. Charbonneau, S. Verma, E. M Lonn, et al. The effect of iron status on vascular health Vascular Medicine, May 1, 2006; 11(2): 85 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Ellervik, A. Tybjaerg-Hansen, P. Grande, M. Appleyard, and B. G. Nordestgaard Hereditary Hemochromatosis and Risk of Ischemic Heart Disease: A Prospective Study and a Case-Control Study Circulation, July 12, 2005; 112(2): 185 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E.R. Kartikasari, N. A. Georgiou, F. L.J. Visseren, H. van Kats-Renaud, B. S. van Asbeck, and J. J.M. Marx Intracellular Labile Iron Modulates Adhesion of Human Monocytes to Human Endothelial Cells Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2257 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R Hunt and H. Zeng Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis Am. J. Clinical Nutrition, October 1, 2004; 80(4): 924 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J L Chicharro, J Hoyos, F Gomez-Gallego, J G Villa, F Bandres, P Celaya, F Jimenez, J M Alonso, A Cordova, and A Lucia Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes Br. J. Sports Med., August 1, 2004; 38(4): 418 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G P Feeney, P A L Ashfield-Watt, M L Burr, F D J Dunstan, I F W McDowell, and M Worwood Heterozygosity for the haemochromatosis mutation HFE C282Y is not a risk factor for angina Heart, August 1, 2004; 90(8): 939 - 940. [Full Text] [PDF]
|
|
|
|
|
|
I R Gunn, F K Maxwell, D Gaffney, A D McMahon, and C J Packard Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy Heart, March 1, 2004; 90(3): 304 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Liu, S. E Hankinson, M. J Stampfer, N. Rifai, W. C Willett, and J. Ma Body iron stores and their determinants in healthy postmenopausal US women Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1160 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R Hunt Bioavailability of iron, zinc, and other trace minerals from vegetarian diets Am. J. Clinical Nutrition, September 1, 2003; 78(3): 633S - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Campbell, D K George, S D Robb, R Spooner, T A McDonagh, H J Dargie, and P R Mills The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease Heart, September 1, 2003; 89(9): 1023 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Day, D. Duquaine, L. V. Mundada, R. G. Menon, B. V. Khan, S. Rajagopalan, and W. P. Fay Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis Circulation, May 27, 2003; 107(20): 2601 - 2606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Surber, H H Sigusch, H Kuehnert, and H R Figulla Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography J. Med. Genet., May 1, 2003; 40(5): e58 - 58. [Full Text] [PDF]
|
|
|
|
|
|
M. Hambidge Biomarkers of Trace Mineral Intake and Status J. Nutr., March 1, 2003; 133(3): 948S - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Beutler, A. V. Hoffbrand, and J. D. Cook Iron Deficiency and Overload Hematology, January 1, 2003; 2003(1): 40 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Halonen, J. Mattila, P. Suominen, T. Ruuska, M. K. Salo, and A. Makipernaa Iron Overload in Children Who Are Treated for Acute Lymphoblastic Leukemia Estimated by Liver Siderosis and Serum Iron Parameters Pediatrics, January 1, 2003; 111(1): 91 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gaenzer, P. Marschang, W. Sturm, G.u. Neumayr, W. Vogel, J. Patsch, and G.u. Weiss Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2189 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schumann, B. Borch-Iohnsen, M. W Hentze, and J. J. Marx Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board Am. J. Clinical Nutrition, September 1, 2002; 76(3): 499 - 500. [Full Text] [PDF]
|
|
|
|
|
|
C. T Sempos Do body iron stores increase the risk of developing coronary heart disease? Am. J. Clinical Nutrition, September 1, 2002; 76(3): 501 - 503. [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Mainous III, J. M. Gill, and W. S. Pearson Should We Screen for Hemochromatosis?: An Examination of Evidence of Downstream Effects on Morbidity and Mortality Arch Intern Med, August 12, 2002; 162(15): 1769 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kletzmayr, G. Sunder-Plassmann, and W. H. Horl High dose intravenous iron: a note of caution Nephrol. Dial. Transplant., June 1, 2002; 17(6): 962 - 965. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ma and M. J. Stampfer Body Iron Stores and Coronary Heart Disease Clin. Chem., April 1, 2002; 48(4): 601 - 603. [Full Text] [PDF]
|
|
|
|
|
|
C. Bozzini, D. Girelli, E. Tinazzi, O. Olivieri, C. Stranieri, A. Bassi, E. Trabetti, G. Faccini, P. F. Pignatti, and R. Corrocher Biochemical and Genetic Markers of Iron Status and the Risk of Coronary Artery Disease: An Angiography-based Study Clin. Chem., April 1, 2002; 48(4): 622 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pastinen, M. Perola, J. Ignatius, C. Sabatti, P. Tainola, M. Levander, A.-C. Syvanen, and L. Peltonen Dissecting a population genome for targeted screening of disease mutations Hum. Mol. Genet., December 1, 2001; 10(26): 2961 - 2972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bathum, L. Christiansen, H. Nybo, K. A. Ranberg, D. Gaist, B. Jeune, N. E. Petersen, J. Vaupel, and K. Christensen Association of Mutations in the Hemochromatosis Gene With Shorter Life Expectancy Arch Intern Med, November 12, 2001; 161(20): 2441 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haidari, E. Javadi, A. Sanati, M. Hajilooi, and J. Ghanbili Association of Increased Ferritin with Premature Coronary Stenosis in Men Clin. Chem., September 1, 2001; 47(9): 1666 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. N. Day, D. Gu, R. H Ganderton, E. Spanakis, and S. Ye Epidemiology and the genetic basis of disease Int. J. Epidemiol., August 1, 2001; 30(4): 661 - 667. [Full Text] [PDF]
|
|
|
|
|
|
E. Rossi, M. K. Bulsara, J. K. Olynyk, D. J. Cullen, L. Summerville, and L. W. Powell Effect of Hemochromatosis Genotype and Lifestyle Factors on Iron and Red Cell Indices in a Community Population Clin. Chem., February 1, 2001; 47(2): 202 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ascherio, E. B. Rimm, E. Giovannucci, W. C. Willett, and M. J. Stampfer Blood Donations and Risk of Coronary Heart Disease in Men Circulation, January 2, 2001; 103(1): 52 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rossi, B. M. McQuillan, J. Hung, P. L. Thompson, C. Kuek, and J. P. Beilby Serum Ferritin and C282Y Mutation of the Hemochromatosis Gene as Predictors of Asymptomatic Carotid Atherosclerosis in a Community Population Stroke, December 1, 2000; 31(12): 3015 - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Curtis, J. T Salonen, T.-P. Tuomainen, and K. Kontula C282Y mutation and type 2 diabetes BMJ, November 18, 2000; 321(7271): 1288b - 1288. [Full Text]
|
|
|
|
|
|
N G Mahon, A S Coonar, S Jeffery, F Coccolo, J Akiyu, B Zal, R Houlston, G E Levin, C Baboonian, W J McKenna, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy Heart, November 1, 2000; 84(5): 541 - 547. [Abstract] [Full Text]
|
|
|
|
|
|
G. G. Donohoe, M. Laaksonen, K. Pulkki, T. Ronnemaa, and V. Kairisto Rapid Single-Tube Screening of the C282Y Hemochromatosis Mutation by Real-Time Multiplex Allele-specific PCR without Fluorescent Probes Clin. Chem., October 1, 2000; 46(10): 1540 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T Salonen, T.-P. Tuomainen, and K. Kontula Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study BMJ, June 24, 2000; 320(7251): 1706 - 1707. [Full Text]
|
|
|
|
|
|
J. L Sullivan Correspondence: The iron hypothesis: claim vs. hypothesis Vascular Medicine, May 1, 2000; 5(2): 127 - 128. [PDF]
|
|
|
|
 |
|
 P. J. Garry, W. C. Hunt, and R. N. Baumgartner Effects of Iron Intake on Iron Stores in Elderly Men and Women: Longitudinal and Cross-Sectional Results J. Am. Coll. Nutr., April 1, 2000; 19(2): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. P. Walker, B. F. Walker, J. J. M. Marx, and B. de Valk Iron and Ischemic Heart Disease in the African Setting Arch Intern Med, January 24, 2000; 160(2): 241 - 241. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rosen, C.-L. Spetz, N. Hammar, P. Greenland, U. Goldbourt, L. Cao, W. Song, D. L. Ornstein, L. R. Zacharski, V. Vaccarino, et al. Coronary Artery Disease in Men and Women N. Engl. J. Med., December 16, 1999; 341(25): 1931 - 1935. [Full Text]
|
|
|
|
|
|
J. L. Sullivan Iron and the Genetics of Cardiovascular Disease Circulation, September 21, 1999; 100(12): 1260 - 1263. [Full Text] [PDF]
|
|
|
|
|
|
M. Roest, Y. T. van der Schouw, B. de Valk, J. J. M. Marx, M. J. Tempelman, P. G. de Groot, J. J. Sixma, and J. D. Banga Heterozygosity for a Hereditary Hemochromatosis Gene Is Associated With Cardiovascular Death in Women Circulation, September 21, 1999; 100(12): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Topol, J. McCarthy, S. Gabriel, D. J. Moliterno, W. J. Rogers, L. K. Newby, M. Freedman, J. Metivier, R. Cannata, C. J. O'Donnell, et al. Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction Circulation, November 27, 2001; 104(22): 2641 - 2644. [Abstract] [Full Text] [PDF]
|
|